Department of Medicine, Division of General Internal Medicine.
Center for Advancing Population Sciences, Medical College of Wisconsin, Milwaukee, WI.
Med Care. 2022 Oct 1;60(10):768-774. doi: 10.1097/MLR.0000000000001761. Epub 2022 Aug 10.
Effective January 1, 2021, US hospitals were required to upload information on their chargemaster prices (database of list prices), discounted cash prices (commonly charged to self-pay patients), and payer-specific negotiated prices.
Examine how prices vary and are associated with hospital characteristics, market competition, and hospital quality.
This observational study used data on 14 common medical services across 1599 hospitals in 2021. Descriptive and regression analyses were used to study price variation. Analyses adjust for hospital characteristics, market competition and state fixed effects.
Ninetieth -to-10th-percentile price markups factors (ratios) range between 3.2 and 11.5 for chargemaster; 6.1 and 19.7 for cash; and 6.6 and 30.0 for negotiated prices. Adjusted regression results indicate that hospitals' cash prices are on average 60% ( P <0.01) higher, and list prices are on average 164% ( P <0.01) higher, than negotiated prices. Systematic pricing differences across hospitals were noted, with urban hospitals having 14% ( P <0.01) lower prices than rural hospitals, teaching hospitals having 3% ( P <0.01) higher prices than nonteaching hospitals, and nonprofit hospitals pricing 9% ( P <0.01), and for-profit hospitals 39% ( P <0.01), higher than government owned hospitals. In addition, hospitals that contract with more insurance plans have higher prices, hospitals in more competitive markets have lower prices, and higher quality hospitals have on average 5% ( P <0.01) lower prices than lower quality hospitals.
Prices all vary considerably across US hospitals. High quality hospitals are associated with lower pricing across all three sets of prices examined. Hospital price transparency may help consumers better identify hospitals that provide both high quality, and low cost, care.
自 2021 年 1 月 1 日起,美国医院被要求上传其计费器价格(标价数据库)、现金折扣价格(通常向自付患者收取)和按付款人协商的价格信息。
研究价格如何因医院特征、市场竞争和医院质量而变化。
设计、设置和参与者:本观察性研究使用了 2021 年 1599 家医院 14 种常见医疗服务的数据。使用描述性和回归分析来研究价格变化。分析调整了医院特征、市场竞争和州固定效应。
第 90 百分位到第 10 百分位的加价因素(比率)范围为 3.2 至 11.5,适用于计费器;6.1 至 19.7,适用于现金;6.6 至 30.0,适用于协商价格。调整后的回归结果表明,医院的现金价格平均高出 60%(P<0.01),标价平均高出 164%(P<0.01)。医院之间存在系统性定价差异,城市医院的价格比农村医院低 14%(P<0.01),教学医院的价格比非教学医院高 3%(P<0.01),非营利性医院的价格比政府所有医院高 9%(P<0.01),营利性医院的价格比政府所有医院高 39%(P<0.01)。此外,与更多保险公司签订合同的医院价格较高,市场竞争激烈的医院价格较低,而质量较高的医院的平均价格比质量较低的医院低 5%(P<0.01)。
美国医院的价格差异很大。在检查的所有三组价格中,高质量医院的价格都较低。医院价格透明度可能有助于消费者更好地识别既提供高质量又提供低成本护理的医院。